In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.

MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa. This new agent was more active than any of the other antibiotics tested, which included carbenicillin, ampicillin, cephalexin, tetracycli...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Downs, J, Andriole, V T, Ryan, J L
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 1982
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181965/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6211142/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.4.670
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!